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ABSTRACT
Infective endocarditis (IE) may have devastating and life-threatening neurological complications. 
The incidence of intracranial hemorrhage (e.g. subdural hematoma, subarachnoid hemorrhage 
(SAH), and intracerebral hemorrhage(ICH)) is rare. A 39 years old male, came to emergency unit 
with heart failure clinical features, accompanied with fever for 2 weeks, and apical systolic murmur 
found in the physical examination. In the second day of admission, the patient experienced a 
sudden decrease of conciousness, weakness of the right limbs, and slurred speech. CT scan 
examination showed left parietal lobe ICH with volume ± 20 cc, and SAH in left parietal lobe, basal 
systern, to pontine systern. Echocardiography revealed AML flail with severe mitral regurgitation 
and vegetation in AML. Empirical parenteral antibiotics ceftriaxone and gentamicin were given. 
In the following day, the conciousness was increasing. Later, the blood culture examination 
showed growing of Staphylococcus saprophyticus.Intracranial hemorrhage may cause worsening 
in patient’s condition, and require withdrawal in anticoagulant therapy. Cardiac surgery should 
be delayed.Despite of its uncommon incidence, physician should be aware of the neurological 
complication of IE to recognize and do the prompt treatment of the disease.
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INTISARI
Endokarditis infektif (EI) dapat menimbulkan komplikasi neurologis yang dapat mengancam 
nyawa. Insiden dari perdarahan intrakranial (yaitu hematoma subdural, perdarahan subaraknoid 
(SAH), dan perdarahan intraserebral (ICH)) sangat jarang terjadi. Seorang laki-laki 39 tahun 
datang ke unit gawat darurat dengan gejala klinis gagal jantung, disertai dengan demam 
selama 2 minggu, dan murmur sistolik di apeks ditemukan dalam pemeriksaan fisik. Pada 
hari kedua rawat inap, pasien mengalami penurunan kesadaran mendadak, kelemahan pada 
tubuh sebelah kanan, dan bicara pelo. Hasil pemeriksaan CT scan menunjukkan adanya ICH 
di lobus parietal kiri dengan volume ± 20 cc, dan SAH di lobus parietal kiri, sisterna basalis 
dan sisterna pontine. Ekhokardiografi menunjukkan adanya AML flail dengan mitral regurgitasi 
berat dan vegetasi di AML. Antibiotik parenteral empiris yaitu ceftriaxone dan gentamisin 
diberikan pada pasien. Hari berikutnya, kesadaran pasien mulai meningkat. Hasil dari kultur 
darah menunjukkan pertumbuhan Staphylococcus saprophyticus.Perdarahan intrakranial 
dapat menyebabkan perburukan dari kondisi pasien, dan penggunaan terapi antikoagulan 
sebaiknya dihantikan. Operasi jantung juga sebaiknya ditunda. Walaupun insidensnya tidak 
banyak, dokter harus mengetahui komplikasi neurologis dari IE untuk dapat mengenali dan 
memberikan terapi yang tepat.
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INTRODUCTION
Infective endocarditis (IE) is still a major 
clinical problem due to its high morbidity 
and mortality rates. Its various complications 
could worsen the patients’ condition especially 
neurological complications. Neurological 
complications that manifests into symptoms 
happen in approximately 15-30% of patients 
of IE.1,2 It ranges from ischemic stroke or TIA, 
cerebral hemorrhage, cerebral microbleeds, 
cerebral abcess, mycotic aneurysms, meningitis, 
and toxic encephalopathy with embolic cases 
as the most frequent,3  those neurological 
diseases were described as the presenting 
symptom in 47% cases,3 with an embolic event 
as the most frequent manifestation (23/55; 
42% Cerebral hemorrhage occur in 12-30% 
of neurological complication in IE.1,3 In our 
knowledge subarachnoid hemorrhage (SAH) 
and intracerebral hemorrhage (ICH) in IE are 
uncommon, and rarely reported happen in the 
same patient in case presentation.
Neurological complications could affect the 
choice of treatment for IE. The management of 
IE requires combination of medical and surgical 
approach, the benefit and the risk have to be 
balanced to choose the prompt therapy.4 In some 
cases the indication of cardiac surgery remained, 
meanwhile in other cases the poor neurological 
prognosis delayed the surgery.4 
This case report describes the case of ICH 
and SAH as the complication of IE and discuss 
the management of the case compared with the 
guideline.
CASE PRESENTATION
A 39 years old male came to emergency 
department with shortness of breath especially 
after walking in a distance and also when lying 
down sleeping one week before admission. He 
often woke up at night because of the shortness 
of breath and more comfortable in sitting position. 
He suffered from cough with white sputum 
and swelling of both legs. Two weeks before 
admission he had low grade fever. He also felt 
stomach  discomfort and joint pain. The patient 
didn’t have history of similar symptoms before, 
no chest pain, and no history of hypertension. 
History of intravenous drug use, or predisposing 
heart condition such as prosthetic valve surgery 
were also denied.
In physical examination, the patient was 
compos mentis with GCS 456, blood pressure 
111/84 mmHg, heart rate 126 bpm, respiratory 
rates 25 times per minute, with temperature 
37.1 oC. Systolic murmur was found in the apex, 
and he had leg edema. Laboratory examination 
revealed slight decrease of hemoglobin (10.4 
g/dl) , rise of platelet(439.000/µl and AST level 
(54 U/L), the other were within normal limitation.
Thorax x-ray was performed and showed 
bilateral pleural effusion and slight cardiomegaly. 
Electrocardiogram (ECG) revealed sinus rythm 
120 bpm with occasional ventricular extrasystole 
(VES). The patient was assessed with heart 
failure NYHA functional class II and suspect 
mitral regurgitation. Ringer lactate infusion 
Figure 1. Thorax x ray examination showed 
bilateral pleural effusion and slight cardiomegaly
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500 cc /24 hours, furosemide 20 mg injection, 
and omeprazole 40 mg injection were given. 
Abdominal ultrasonography was performed and 
revealed no abnormality in the abdomen.
In the second day of admission, patient had 
fever with 39oC body temperature. White blood 
cell increased (17.300/µl). ECG examination 
showed anteroseptal ischemia however the 
CKMB was within normal limit. Paracetamol 
500 mg tid, isosorbide dinitrate 5 mg tid and 
clopidogrel 75 mg once a day were planned to be 
given, when suddenly the patient had decrease 
of conciousness with Glasgow Coma Scale 3-2-
5 and slurred speech. There were right facial 
palsy, and right lateralization. Non contrast head 
CT scan revealed ICH at left parietal lobe with 
perifocal edema causing midline shift 0.6 cm to 
the right, and SAH in left parietal, basal systern, 
until pontine systern. The patient was moved to 
high care unit. Neurologist consultant suggested 
intravenous piracetam 3 gram injection tid, 
nimodipine 60 mg oral qid, and metamizole 
injection tid. Clopidogrel administration was 
delayed and intravenous ceftriaxon 1 gram bid 
was given.
In the following day, echocardiography 
was performed and showed severe mitral 
regurgitation, anterior mitral leaflet (AML) 
flail with Vmax 4.90 m/s, trivial tricuspid 
regurgitation, normal left ventricle, slight left 
ventricle hypertrophy, and vegetation in AML. 
Systolic and diastolic function of left ventricle 
was normal with ejection fraction (EF) by Teich 
67.08% and mitral E/A ratio 1.97. Renal function 
test revealed normal serum creatinine and 
ureum. Intravenous gentamicin injection 80 mg 
bid was added in the therapy. In the next day, 
the conciousness improved with GCS 4-4-6, 
however the blood pressure dropped into 90/50 
mmHg. Intravenous dopamin 5 meq was given 
to the patient and nimodipine was stopped. After 
that the patient’s blood pressure rose into 110/80 
mmHg and the dopamin was withdrawn after 2 
days. The patient also had hematuria, however 
urinalysis did not manage to be performed. 
Later, the blood culture result was the growing 
of Staphylococcus saprophyticus which was 
sensitive to linezolid, tigecyclin, nitrofurantoin, 
rifampicin, and trimethoprim/sulfamethoxazole. 
Unfortunately, the patient did not want to continue 
to receive treatment in hospital due to financial 
problem. 
 In the second day of admission, patient had fever with 39oC body temperature. 
White blood cell increased (17.300 / µl).  ECG examination showed anteroseptal 
ischemia however the CKMB was within normal limit. Paracetamol 500 mg tid, 
isosorbide dinitrate 5 mg tid and clopidogrel 75 mg once a day were planned to be 
given, when suddenly the patient had decrease of conciousness with Glasgow Coma 
Scale 3-2-5 and slurred speech. There were right facial palsy, and right lateralization. 
Non contrast head CT scan revealed ICH at left parietal lobe with perifocal edema 
causing midline shift 0.6 cm to the right, and SAH in left parietal, basal cystern, until 
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Figure 2. ICH and SAH in left parietal lobe shown in CT scan examination 
In the following day, echocardiography was performed and showed severe 
mitral regurgitation, anterior mitral leaflet (AML) flail with Vmax 4.90 m/s, trivial tricuspid 
regurgitation, normal left ventricle, slight left ventricle hypertrophy, and vegetation in 
AML. Systolic and diastolic function of left ventricle was normal with ejection fraction 
(EF) by Teich 67.08% and mitral E/A ratio 1.97. Renal function test revealed normal 
serum creatinine and ureum. Intravenous gentamicin injection 80 mg bid was added in 
the therapy. In the next day, the conciousness increased with GCS 4-4-6, however the 
blood pre sur  dropped into 90/50 mmHg. Intravenous dopamin 5 meq was given to 
the patient and nimodipine was stopped. After that the patient’s blood pressure rose 
into 110/80 mmHg and the dopamin was withdrawn after 2 days. The patient also had 
hematuria, ho ever urinalysis did not manage to be performed. Later, the blood culture 
result was the growing of Staphylococcus saprophyticus which was sensitive to 
linezolid, tigecyclin, nitrofurantoin, rifampicin, and trimethoprim/sulfamethoxazole. 
Unfortunately, the patient did not want to continue to receive treatment in hospital due 
to financial problem.  
 
 
 
Figure 3. Transthoracal echocardiography showed vegetation in AML  
DISCUSSION 
 We reported a case of male patient, 39 years old with IE presented with heart 
failure (HF) manifestation accompanied by fever. In the second day of admission, the 
patient had a sudden decrease of conciousness caused by ICH and SAH. The 
diagnosis of IE was established through applying Dukes criteria with 1 major and 3 
Figure 2. ICH and SAH in left parietal lobe shown 
in CT scan examination
Figure 3. Transthoracal echocardiography 
showed vegetation in AML 
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DISCUSSION
We reported a case of male patient, 39 
years old with IE presented with heart failure 
(HF) manifestation accompanied by fever. In 
the second day of admission, the patient had 
a sudden decrease of conciousness caused 
by ICH and SAH. The diagnosis of IE was 
established through applying Dukes criteria with 
1 major and 3 minor criteria. One major criterion 
fulfilled as the echocardiography examination 
showed vegetation in AML. Three minor criteria 
was fever with temperature > 38 oC, vascular 
phenomena which was intracranial hemorrhage, 
and positive blood culture but did not meet a 
major criterion.4
Heart fai lure is the most frequent 
complication found in IE5, mainly caused by a 
new or worsening of valve regurgitation such 
as aortic or mitral valve.6 In this patient systolic 
murmur in apex of the heart was found in the 
physical examination, so the mitral regurgitation 
was suspected. Then, in echocardiography, the 
severe mitral regurgitation was confirmed with 
normal function of left ventricle. We still did not 
know whether the valve regurgitation was new 
or already happened for a long time. Patients 
who develop acute severe mitral regurgitation 
usually present with symptomatic heart failure 
because the ventricles are fail prepared to 
accept the sudden increase in volume load. 
If the patient survives the acute episode or 
has slowly progressive worsening of mitral 
regurgitation, the symptoms are therefore either 
absent or slowly progressive over any years. The 
adaptive changes of the ventricle to the volume 
overload include left ventricle dilatation and 
eccentric hypertrophy. However decompensation 
may eventually develop if the regurgitation is 
sufficiently severe.7 
Neurological complications in IE, stroke in 
particular, are associated with higher mortality 
and morbidity.1,3 The pathological mechanism 
of intracranial bleeding are wide ranging, from 
the hemorrhagic conversion of infarcted area 
secondary to septic emboli, rupture of intracranial 
mycotic aneurysms (ICMA), until microbleeds 
due to immunologic vasculitis.8–10 
SAH in IE is uncommon and only described 
in case reports. ICMA is classically associated 
with SAH, however non-aneurysmal spontaneous 
SAH could happen in a rare cases.9,11 American 
Heart Association (AHA) recommends computed 
tomogaphic angiography (CTA) and magnetic 
resonance angiography (MRA) to examine the 
patient with neurological symptoms to detect 
cerebral aneurysm.12 ICH in IE also can be the 
result of arterial injury, such as septic arteritis that 
usually occurs during uncontrolled infection.13 
In this case, a very rare ICH and SAH were 
happened at the same time in the left parietal 
lobe area. However, further studies to know what 
caused the bleeding could not be done due to 
the limitation of the resources.
The general principle of successful 
treatment of IE relies on microbial eradication 
by anti-microbial drugs. Surgery contributes 
by removing infected material and draining 
abscesses.4 Early diagnosis and administration 
of appropriate antibiotics are also important in 
preventing neurological complication.14 Empirical 
treatment should be started promptly before 
the blood culture result out. For choosing the 
empirical antibiotic several things had to be 
considered such as previous antibiotic therapy, 
native or prosthetic valve, and local epidemiology 
of antibiotic resistance.4 
Proposed antibiotic regimens for initial 
empirical treatment for native valves were 
ampicillin with (flu)cloxacilin or oxacilin with 
gentamicin (class IIa, level C), or vancomycin 
with gentamicin (class IIb, level C).4 In this patient, 
ceftriaxone with gentamicin were given based on 
the antibiotic resistance mapping in our hospital. 
Later, the culture showed Staphylococcus 
saprophyticus sensitive to linezolid, tigecyclin, 
nitrofurantoin, r i fampicin, tr imethoprim/
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sulfamethoxazole. In the guideline for coagulase 
negative staphylococci, cotrimoxazole combined 
with clindamycin were recommended (class 
IIb, level C)4 and it matched with the result of 
blood culture. Appropriate antibiotics should be 
given but unfortunately the patient did not want 
to continue receiving care at hospital so the 
physician could not monitor the administration 
of the drugs and the patient’s outcome.
Heart surgery is indicated in IE patient with 
HF symptoms especially in the cases that caused 
by severe aortic or mitral regurgitation.4 However, in 
patients with HF functional class I or II with severe 
valvular regurgitation and no other reasons for 
surgery, antibiotic administration under strict clinical 
and echocardiographic observation is a good 
option, although early surgery may be an option 
in selected patients at low risk for surgery.4 Based 
on the recommendation, intracranial hemorrage 
also made the surgery should be delayed for at 
least 1 month (class IIa, level B).4 In IE patients 
with neurological complications, clinical assesment, 
cerebral CT scan or MRI and echocardiography 
should be done to detect the comorbidity such 
as heart failure, uncontrolled infection, abcess, 
and risk of embolism. If those factors are present, 
the severe neurological complications are being 
assessed including intracranial haemorrhage, 
coma, severe comorbidities, or stroke with 
severe damage. If there is no severe neurological 
complications, heart surgery is considered. 
Otherwise if there are comorbidities and severe 
neurological complications, conservative treatment 
and monitoring should be performed.4 So in this 
patient, the cardiac surgery was not indicated at 
that time.
The recommendations for management of 
anticoagulant therapy in IE patients are based on 
low level evidence. Study stated that consuming 
anticoagulant during IE development may diminish 
early embolic tendencies.15 However, in intracranial 
hemorrhage, interuption of all anticoagulation is 
recommended (class I, level C).4
CONCLUSION
Neurological complications might present 
in IE with higher morbidity and mortality. The rare 
form of neurological complications, intracranial 
hemorrhage, may cause worsening in patient’s 
condition, and require withdrawal in anticoagulant 
therapy. Cardiac surgery should be delayed.
Despite of its uncommon incidence, physician 
should be aware of the neurological complication 
of IE to recognize and do the prompt treatment 
of the disease.
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